Safety study using focused ultrasound for certain brain tumors
Part of Cancer clinical trials.
This study tests whether a focused ultrasound treatment is safe for children and young adults who have a non-cancerous (benign) tumor in the center of the brain. It mainly checks safety, and it also includes monitoring before and during treatment to reduce risks like bleeding or imaging-related problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a non-cancerous tumor in the central brain (grade 1) that doctors say has a low bleeding risk
- Your head size meets the study minimum (head circumference at least 49 cm)
- You meet an MRI measurement requirement called Skull Density Ratio (SDR) of 0.35 or higher
- You’ve been on the same condition-related medications for at least 30 days, and you can provide records to confirm it
- You can keep a seizure diary (paper or log) for 30 days before treatment and during the study
- Your body can safely undergo MRI: no MRI-incompatible implanted metal devices, and you’re not allergic to MRI contrast or sedating medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if combining focused ultrasound (which opens the blood-brain barrier) with the immunotherapy drug nivolumab can treat relapsed or progressive brainstem gliomas and other high-grade brain tumors in children and young adults.
This research study uses focused ultrasound waves combined with brain electrodes (already implanted for your epilepsy or psychiatric treatment) to map how your brain responds. The goal is to better understand brain function and potentially improve future treatments.
This study looks at using focused ultrasound to temporarily loosen the brain’s “blood barrier” around certain brain tumors, while people still get standard surgery. It aims to help doctors learn how safe the approach is and collect blood/fluid samples during the operation.
This trial tests a non-invasive procedure called magnetic resonance-guided focused ultrasound (MRgFUS) to treat epilepsy caused by brain lesions in children. This approach uses sound waves to target and destroy the lesion without surgery, which may reduce seizures.
This study tests the safety of a brain stimulation approach that uses special brain recording and “focused ultrasound” targeted by brain signals. It is designed for healthy adults and checks whether the procedure is tolerated without serious side effects.
This trial tests whether focused ultrasound can help people whose seizures are not controlled by two or more medications. You would have a noninvasive procedure while awake, pressing a stop button if needed, and your hair will be partially shaved.
Hear when a new Benign Centrally-Located Intracranial Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.